Researchers have found that targeted delivery of messenger RNA (mRNA) can restore sperm production and fertility in ...
11don MSN
US FDA commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost
By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday ...
Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
A settlement provides a massive windfall for Arbutus and Roivant and avoids a worst-case scenario for Moderna.
Arbutus and Genevant's complaint claimed that Moderna's mRNA-based Spikevax shot used lipid nanoparticle (LNP) delivery ...
Drugs made of mRNA have the potential to transform medicine—if only they could get into cells in one piece. Now, University ...
In August last year, the Health Department cut around $500 million in mRNA research funding, with Health Secretary Robert F.
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
Moderna (MRNA) stock jumped 8.7% after announcing a $950M patent settlement with Arbutus and Genevant, the largest pharma patent deal ever recorded.
The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA flu vaccine candidate after holding a high-priority meeting with the company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results